Are there significant gains ahead for one (or both) of these innovative biotechs?
With the power to rewrite the genetic code underlying countless diseases, CRISPR holds immense promise to revolutionize medicine. But until scientists can deliver its gene-editing machinery safely and ...
Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping the future of medicine and genetics.
CRISPR-based genome editing has transformed biological research. Since the advent of the technology in 2012, Addgene has ...
Researchers at Cornell University have developed a safer and more precise way to study how genes function in living tissues by refining a recently developed CRISPR-based genetic technique in fruit ...
Morning Overview on MSN
A new gene-editing treatment just drove back advanced stomach and colon cancers in an early trial — by reprogramming patients’ own immune cells to hunt the tumors
Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, ...
Novel CRISPR-Cas9 treatments are proving effective in reversing disease for life. But ensuring their long-term safety will ...
Learn how CRISPR ETFs provide access to the gene-editing revolution, offering investors a diversified approach without picking individual biotech stocks.
In the never-ending quest to discover previously unknown CRISPR gene-editing systems, researchers have scoured microbes in everything from hot springs and peat bogs to poo and even yogurt. Now, thanks ...
It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results